Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy

Y Liu, Y Li, Y Wang, C Lin, D Zhang, J Chen… - Journal of Hematology & …, 2022 - Springer
therapy of the dual epidermal growth factortumor in phase II clinical trial (NCT00326495).
Secondly, aberrant expression of VEGFR and genetic alteration of fibroblast growth factor

Epidermal growth factor receptor based active targeting: a paradigm shift towards advance tumor therapy

M Habban Akhter, N Sateesh Madhav… - Artificial Cells …, 2018 - Taylor & Francis
… Since then, several other growth factors and their receptors have been disclosed and …
The solid tumor of human has significant level of growth factor receptors. The growth factor

Hepatocyte growth factor, a key tumor-promoting factor in the tumor microenvironment

BY Owusu, R Galemmo, J Janetka, L Klampfer - Cancers, 2017 - mdpi.com
… secrete growth factors, cytokines and extracellular matrix proteins which promote growth, …
Fibroblasts are the predominant constituent of the tumor stroma and Hepatocyte Growth Factor (…

Transforming growth factor-β: A therapeutic target for cancer

S Haque, JC Morris - Human vaccines & immunotherapeutics, 2017 - Taylor & Francis
growth factor-β receptor-2 (TβRII) with high affinity. This binding requires the participation
of the transforming growth factor-β … Targeted tumor therapy with the TGF-beta 2 antisense …

Tissue factor and cancer: regulation, tumor growth, and metastasis

Y Hisada, N Mackman - Seminars in thrombosis and …, 2019 - thieme-connect.com
… The TF/factor VIIa complex enhances tumor growth by activating protease-activated … of
angiogenic factors, such as vascular endothelial growth factor. AsTF increases tumor growth by …

Ten years of anti-vascular endothelial growth factor therapy

N Ferrara, AP Adamis - Nature reviews Drug discovery, 2016 - nature.com
… Placenta growth factor (PlGF) and VEGFB bind selectively to VEGF receptor 1 (VEGFR1), …
certain growth factors such as hepatocyte growth factor and connective tissue growth factor, …

[HTML][HTML] Tumor angiogenesis: Current challenges and therapeutic opportunities

FH Al-Ostoot, S Salah, HA Khamees… - Cancer Treatment and …, 2021 - Elsevier
… of oxygen, nutrients, and growth factors as well as tumor dissemination to distant organs. …
solid tumors that depend on cutting or at least reducing the blood supply to tumor micro-…

The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications

R Tamura, T Tanaka, Y Akasaki, Y Murayama… - Medical Oncology, 2020 - Springer
… Vascular endothelial growth factor (VEGF) is a key mediator of tumor angiogenesis … factor
and its receptor [29]. TAMs induce various growth factors such as basic fibroblast growth factor, …

Vascular endothelial growth factor, a key modulator of the anti-tumor immune response

M Geindreau, F Ghiringhelli, M Bruchard - International journal of …, 2021 - mdpi.com
… in the anti-tumor immune response. In addition, we summarize therapeutic strategies based
… cleave the extracellular matrix and release heparin bound growth factor such as VEGF-A [38]…

Trends and challenges in tumor anti-angiogenic therapies

J Jászai, MHH Schmidt - Cells, 2019 - mdpi.com
growth factor (VEGF). VEGF-mediated signaling has quickly become one of the most
promising anti-angiogenic therapeutic … is severely limited in certain tumor types or shows only …